MyeNews Spring 2018 Issue no 47 - Myeloma Australia
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Contents President’s Report In this issue From the President 3 Profile – Geo Sobrio 4 Profile – Sam Zeps & Jacqueline Tate 5 Information and Support Group Initiative 6 Exercise as Medicine 7 News from the Myeloma and Related Diseases Registry 9 My Myeloma Journey 10 Telephone Support Feedback Project 10 Fundraising 12 What’s Happening – Fundraising 13 From the Nurse Manager 14 What’s Happening – New South Wales 15 What’s Happening – South Australia 16 What’s Happening – Victoria 17 What’s Happening – Western Australia 18 Medical Corner 19 Calendar of Events 21 MyeNews – Contact Information and Submissions For feedback, comments, questions or stories for consideration Contact Pina Civitarese: (03) 9428 7444 (toll free) 1300 632 100 pina@myeloma.org.au If you no longer wish to receive the MyeNews please let us know. Design & layout: Greg Loveder Graphics Printed by Eastern Press Find us on Facebook and Twitter Front cover photo: A profusion of flowers and blossoms heralding spring. Office Hours: 9am – 5pm Monday to Friday AEST Head Office: 333 Swan Street, Richmond, VIC 3121 Post: PO Box 5017 Burnley, VIC, 3121 MyeNews is supported by T: 1300 632 100 (toll free) T: (03) 9428 7444 an unrestricted educational grant from Celgene MyeNews is published quarterly by the Myeloma Foundation of Austalia Inc. The information presented in MyeNews is not intended to take the place of medical care or the advice of a doctor. Your doctor should always be consulted regarding diagnosis and treatment. No part of this newsletter may be reproduced in any form without the prior written permission from The Myeloma Foundation of Australia Inc. Myeloma Foundation of Australia Inc. ARBN 126 035 247 ABN 30 476 390 368 2 MyeNews | www.myeloma.org.au
From the President It is hard to believe that Myeloma Australia will Myeloma Australia has celebrate its 20th birthday this year. It does not decided to celebrate our birthday by introducing seem that long ago that I met with Robert and awards to those volunteers Glenys Moran, the Brown family, Pat Dobson who have helped make this of the Cancer Council Victoria, Professor Miles all possible. This year we are Prince and Associate Professor Paul Mitchell at making our first batch of the offices of the Cancer Council with the idea volunteer recognitions and of starting a myeloma support organisation in each year going forward we will recognise those people August 1998. who have made a volunteer contribution to myeloma In May 1999 Myeloma Victoria was incorporated and the patients in Australia. We committee included Robert and Glenys, Pat Dobson, Leanne have three levels of awards with the first two groups being Lambert, a social worker and myself. Prof. Prince and A/Prof presented at events in their capital cities and the top awards Mitchell were permanent advisors to our board. will be presented at the 2nd National Myeloma Scientific We met every couple of months and our first big event was Workshop in September. Award recipients will be notified a patient seminar in April 1999 at the Crest Hotel in St Kilda. soon and all the awardees will be in the next edition of We had about 250 people attend the day listening MyeNews. to presentations on all aspects of myeloma given by The National Myeloma Scientific Workshop that we are Professors Doug Joshua, Miles Prince, Jeff Szer and Associate holding in September is held every second year and we invite Professor Paul Mitchell. This event far exceeded our researchers from Australia and New Zealand to present their expectations and gave us the incentive to keep building our work to their peers. Also, we have invited three international organisation as we saw the real need in the community for haematologists who will speak on their research. support and education. With the growth of Myeloma Australia our need for funding In early 2000 we employed our first Myeloma Support Nurse increases and I thank the all our corporate supporters for and started the 1800 telephone support service which is still their generous support. I would also like to thank those going strongly today. members of the myeloma community who have held fund In about 2002 Professor Doug Joshua chaired a meeting of a raising events, run or walked in the many fun runs or those number of groups with an interest in myeloma from all over who have just donated, your money is necessary for us to Australia to discuss the forming of an Australian organisation. maintain and grow the level of service we are supplying. After this meeting we joined with a group based in Liverpool, We are still a very small organisation with one full time staff Sydney run by Shaun and Linda Raby and one from Adelaide member in Steve our CEO and six part time staff assisting run by Ian Driver, to start Myeloma Australia (Myeloma with fundraising and administration. I would like to thank Foundation of Australia Inc.) Steve as it has been under his guidance that we have really Our next step was to employ a Myeloma Support Nurse grown always along the directions set by the original in both Adelaide and Sydney. Over the following years we Myeloma Victoria Board. Boy have we come a long way in formed a number of support groups and ran a number of twenty years! patient seminars both in the capital cities as well as in the I would like to add a personal comment as this year marks country centres. my wife Roslyn’s 22nd year since diagnosis with myeloma At long last we are now a truly national organisation and 21st year since a stem cell transplant and this year we with Myeloma Support Nurses based in Perth, Adelaide, celebrate our 50th wedding anniversary. This is something Melbourne, Sydney, Brisbane and shortly in Newcastle and we never expected to reach and we make sure that we do Tasmania as planning progresses. The Northern Territory not take anything for granted. is covered from Adelaide and Canberra is covered from Keep hanging in there as there are new drugs being Sydney. Tasmania will soon have a Myeloma Australia nurse developed and hopefully we will see in our lifetime myeloma though presently this is covered from Melbourne. From the being classified as a chronic disease and hopefully a cure. very beginning we decided that we would be a nurse based organisation with all of our services run by qualified myeloma nurses. We are the only organisation in the world providing an entirely myeloma nurse based support service to the myeloma community and all of our nurses are among the Brian Rosengarten most knowledgeable myeloma nurses in Australia. One of the President many services they provide is to visit hospitals and present Myeloma Australia myeloma education for the nurses. Support Line 1800 693 566 | MyeNews 3
Profile Geo Sobrio I became a clinical trials coordinator at Royal Prince Alfred Hospital where I was involved in the POLLUX study and the very promising CAR T Cell therapy. It was my first out-of- the-ward job setting and I really enjoyed the variety. A few months after that, I took a temporary role at the Australian Red Cross Blood Service. I was a Clinical Nurse Advisor in the management of IVIGs and coordinator for the HLA matched platelets. It was only there that I realized how much IVIGs are needed for the entire NSW community and the tremendous helpfulness of the organization. I was very impressed how I grew with them and became a clinical resource for complex cases. I then decided to study nursing leadership for my next career adventure. It was at the beginning of winter when I joined the team at Myeloma Australia. I instantly enjoyed my new role because of its flexibility and the opportunities to learn deeper, and the gift of more time to listen to patients’ stories as they go on their journey with myeloma. Ever since my first attendance at a support group meeting, I was inspired to reach out to patients and more importantly their carers. I have always been very passionate about empowering my patients and this has been the core of my nursing life. My background in nursing started in 2006. After I finished I will be working every Thursday and Friday each week in our my degree at my hometown in the Philippines, I was rotated newly opened office in Parramatta. On my other days of the to multiple areas in paediatrics, emergency, and surgery week, I run a private chemo clinic for solid tumours (medical but ended up in complex medical unit and stayed there for oncology) and do one day on the weekend at my old haem 5 years. Not long after, I was enjoying my first Australian ward or in ED at the public in Liverpool. summer in 2012 in the quiet and beautiful town of Bendigo. There, I did a bridging program to get me used to the Even though I am very busy, I always find myself strolling Australian health care system and learn the culture of course. and surfing along the beautiful sands in the south coast or at Then few weeks later, I landed a job in Sydney and eventually, the edges of the cliffs of the blue mountains. Over the next Photo supplied and used with permission I called Liverpool my second home. few months, I will be in Adelaide, the Yarra Valley in Victoria and then Brisbane to attend conferences and to meet the It was only when I became a haematology nurse in the myeloma nursing community. It’s going to be great to get inpatient ward of Liverpool Hospital that I learnt so much around the country to learn more about myeloma and meet about blood cancers and myeloma. Looking after patients members of the myeloma community. during intensive chemotherapy and bone marrow transplant requires specialty knowledge so I did post grad study in Regards, stem cell transplantation and it opened the door to more Geo Sobrio specialized haematology roles. Myeloma Support Nurse, NSW The Myeloma Muster The Myeloma Muster is your monthly round up of news from Myeloma Australia. Filled with the latest information on what’s what in the myeloma community, from fundraisers across the country, latest medical information, updates on Support Groups and much more. If you would like to be added to the list for this email only newsletter, please contact us at support@myeloma.org.au or on P: (03) 9428 7444. 4 MyeNews | www.myeloma.org.au
Profiles Sam Zeps Apart from my family and my work in cancer, my other great passion is triathlon, which has become an integral part of my life over the past four years. Working up from short distance to long distance events, it is the longer courses i.e. half ironman and ironman distances that are my favourite. I am currently training for the Busselton half ironman in December with the hopes to do my second full ironman in Port Macquarie next year if my knee holds up, having had surgery on it earlier this year. I remain forever hopeful that I Photo © Pina Civitarese can continue where I left off as I can’t imagine this sport not being a part of my life. Sam Zeps Support Services Jacqueline Tate Just over a year ago now I moved with part of my family from Perth to Melbourne because of a job opportunity for my husband, Nik. When I say part of my family, that’s because I have two step-children (Zen, 21 and Aisha 19), as well as two children of my own (Daniella 8 and Kira 6) and the eldest couldn’t join us due to university commitments in other states. So, our move to the east has significantly affected our family in many ways. Not only have we been separated from one another, but I also had to leave my mother and lifelong friends, and of course the warmer climate of the sunny west. However, with this change has come many fantastic and positive life changing opportunities for us all. Over the last year my focus was settling our daughters into their new school and extracurricular activities. Now, feeling very settled in our new home, I am very happy to be back Hello! My name is Jacqueline. I love my role at Myeloma in the work force and particularly with the opportunity to Australia as Project Manager and Liaison with the wildly enter a new field of work. Over the last 12 years I worked as talented group of clinicians and scientists we call the MSAG a laboratory based graduate research assistant working in (Medical and Scientific Advisory Group). Before joining cancer research; from prostate cancer in my honours year Myeloma Australia, I worked as a scientist investigating to leukaemia’s in subsequent years at the Telethon Institute deafness, cell transplantation and the cochlear implant, for Child Health Research and at the University of Western also working abroad in cancer bioscience and clinical trials. Australia. While I enjoyed the laboratory research, I knew Outside Myeloma Australia I am a passionate advocate for that this was something I no longer wanted to do and that equal access to STEM (Science Technology Engineering and there were other components to cancer care I wanted to Maths), and a volunteer with organisations like Tech Girls are explore and be a part of. I am therefore very excited to have Superheroes. This year I was honoured to be a Future Makers secured a position at Myeloma Australia as I’m now gaining Fellow through CSL Australia and named as a finalist for STEM experience and insight into another integral part of cancer ambassador to parliament. Right now, I am most excited care; the provision of personal support to those with cancer. about the upcoming National Myeloma Scientific Workshop. While not dealing with patients directly I am delighted to be We run this event so that clinicians and scientists from Photo supplied and used with permission able to assist those that do, through the various tasks that around the world can share their knowledge. I also have a are being assigned to me. My hope is that my experience in young family that loves adventure. On our most recent trip to research will bring additional skills to the organisation and Mt Buller the kids went from snowballs to independent skiing contribute to its growth and development. In the short time in two days flat! We are pictured here snorkeling in Northern I have been at Myeloma Australia I have already acquired a greater appreciation of the needs and services required by Queensland. people with myeloma, as well as their family and carers, and Jacqueline Tate I’m honoured to have been given the opportunity to be a Project Manager and Liaison part of this important organisation. Medical and Scientific Advisory Group Support Line 1800 693 566 | MyeNews 5
Information and Support Group Initiative “This is a very special gift For a very special person. The reason, it’s so special is, It’s just for you from us. Whenever you are lonely, Or ever feeling Blue, You only have to hold this gift And know we think of you”. Members of the Beaumaris Myeloma Information and Suapport Group The Beaumaris Information and Support Group have been giving very special gifts to the myeloma community for years. Driven by member Jan Watt, these gifts are carefully considered, fundraised and shared to brighten someone’s day. A successful application to Melbourne’s bayside city council around 7 years ago, awarded the Beaumaris group a grant to set up an office. This grant allowed the group to purchase office items and supported their proposed fund-raising endeavours. The generosity and kindness of the members and the local community, including local businesses, lead to a successful raffle. Prizes were both donated and handmade. Following a generous donation to Myeloma Australia, the group had some money left over. A long discussion on what to do with the extra money lead to an idea to create a ‘Welcome Pack’ for people living with myeloma. These packs were filled with small gifts to help patients on admission or at the time of a stem cell transplant. Receiving positive feedback, the raffle and welcome packs have become an annual project. The Beaumaris Support Group raffle The latest version of the welcome packs contain a note book will be drawn again at their and pens to pass the time. Ear plugs for a decent sleep. Hand October meeting, with special mention sanitizer, antiseptic cream, dove soap and hand cream to to the following fantastic top prizes; a handmade keep the bugs away. Tissues and jellybeans for the ups and table by Ian Crothers created at Bayside Men’s Shed using downs. Lastly a Myeloma Australia support group meeting only recycled timber, a cot quilt handmade by Jan, bottles of Photos supplied and used with permission schedule and the above poem. To quote Jan ‘it is not so much wine from a member’s winery and many gift cards.” what is in the packs but the knowledge that they are not alone and someone cares.’ Did something help you or someone close to you through a transplant? I’d love it hear about it. Send your tips through to It is a team effort and once the packs are created, they are elli.foley@myeloma.org.au . delivered and given out by the transplant coordinator at a Melbourne hospital to those in need of support. Ten very Elli Foley special ‘Welcome Packs’ are shared every four months or so Myeloma Support Nurse with continued appreciation from the recipients. Victoria 6 MyeNews | www.myeloma.org.au
Exercise as Medicine Exercise as Medicine! This seems like quite recommend that for good health we exercise at a moderate a bold statement and probably one that intensity for 150-300 minutes (ie: swimming, walking, light cycling) or 75-150 minutes at a vigorous intensity (fast paced you have not heard often, especially as jogging or fast cycling), plus two to three resistance training myeloma patients. However, the evidence is sessions per week. These numbers can be quite challenging now overwhelming. Everyday there is more to meet; therefore, it is important to remember any exercise and more reporting of clinical and scientific is better than none and that it’s ok to start off slowly, research supporting this type of medicine and increasing the time spent exercising gradually each week. the importance of it being prescribed, together COSA recommends that all people with cancer avoid with traditional treatments, as normal standard inactivity and return to normal daily activities as soon as practice in oncology care. possible following diagnosis. They suggest that all people with cancer should progress towards and, once achieved, maintain participation in at least 150 minutes of moderate The Clinical Oncology Society of Australia (COSA) recently intensity or 75 minutes of vigorous-intensity aerobic activity; released a position statement recommending that exercise and two to three resistance exercise (i.e. lifting weights) be embedded as part of standard practice in cancer care with sessions each week targeting all major muscle groups. evidence supporting exercise as helping to counteract the adverse effects of cancer and its treatment. So why are so few achieving these guidelines? Barriers to exercising have been reported as fatigue, pain, nausea, cost, Assoc. Professor Prue Cormie, one of the leading authors lack of knowledge, time and confidence, no interest in, or of the COSA position statement, stated on a recent friend to exercise with, as well as other health conditions. episode of Insight (SBS) “If the benefits of exercise were Myeloma patients also get to add bone pain, cancer encapsulated into a pill, this pill would be demanded by related fatigue, muscle wasting and serious neurological every patient, prescribed by every doctor and subsidised by complications such as cranial and spinal nerve compression the government.” It is easy to imagine that this would be an as consequences of their extensive treatment protocols to extremely popular pill and one that people would readily this list. accept into their medicine cabinet. Patients with bone lesions have traditionally been advised to It’s known that regular ongoing exercise through all stages avoid high intensity aerobic exercise, resistance training and of the treatment process has been shown to improve impact training, however, recent research into various patient aerobic capacity, increase muscle mass and strength, slow populations with bone metastases has established that a rest or prevent bone mineral density loss, increase quality of life, strategy only hastened decline and reduced survival rates. It reduce fatigue and aid recovery. However, only one in five has now been determined that resistance training and aerobic people diagnosed with cancer are meeting national physical exercise programs that are specifically designed to avoid activity guidelines. The Australian Physical Activity guidelines loading potentially fragile sites are both safe and effective. Photos supplied and used with permission WA Myeloma Association members Paul Sims and Chris Windsor working hard at the Curtin University Health & Wellness clinic, following the advice of their referring Haematologist Dr Brad Augustson to use exercise as medicine. Support Line 1800 693 566 | MyeNews 7
Photos supplied and used with permission It’s easy to understand why patients become confused as to when they should start exercising, what type of activity they should be undertaking, and at what intensity. Achieving the recommended guidelines can also seem somewhat overwhelming especially when you are undertaking strenuous treatment protocols and struggling to complete basic daily activities. It is important to remember that starting slowly and doing any exercise is better than none. Similarly, exercising in a supportive environment with appropriately trained supervision can help ensure that you avoid serious complications and/or injuries. Included in the recent position statement by COSA was the recommendation that patients be referred to an accredited exercise physiologist (AEP) and/or a physiotherapist with experience in cancer care in order for them to receive the best care possible. An AEP is an allied health professional who specialises in the benefits of exercise to help patients with a chronic disease, such as cancer, achieve good health. These health professionals are trained to understand the need for exercise to be individualised to each person’s abilities, experience and health status, and are able to adapt an exercise program to cater for the different stages of cancer diagnosis and treatment related side effects. Patients are able to contact Exercise Sports Science Australia (ESSA) in order to help locate an Accredited Exercise Physiologist experienced in cancer care. ESSA can be contacted via: • phone: 07 3171 3335, • email: info@essa.org.au or by logging onto the website and searching for an AEP in the required area using the below address • https://www.essa.org.au/find-aep/ • https://www.cosa.org.au http://exerciseright.com.au By Debbie Cooper Exercise physiologist 8 MyeNews | www.myeloma.org.au
NEWS FROM NEWS FROMTHE THEMYELOMA MYELOMAANDAND RELATED DISEASES RELATED DISEASESREGISTRY REGISTRY MRDR RECRUITMENT As of August 2018, close to 2300 patients Hospitals in New Zealand; private practices Hospital on board soon completing MRDR MRDR RECRUITMENT have been registered on the MRDR. Thank at Adelaide Cancer Centre and Jarrett St representation in all states and territories in As you to all participants of August to 2300 patients Specialist and participating 2018, close Centre, Hospitals in Gosford; and Lismore New Zealand; Australia. WeHospital private practices are certainly in the midst on board soonofcompleting M hospitals have been for your support. registered TheMRDR. on the number Thank of Hospital in NSW. Our at Adelaide coverage Cancer Centre and JarrettaSt in New growth spurt! This is fantastic; representation thanks in all for and territo states hospital / clinic sites continues to increase Zealand has grown considerably and all your efforts at contributing sites and for you to all participants and participating Specialist Centre, Gosford; and Lismore Australia. We are certainly in the mids with 34 approved sites on board, and greater representation in Queensland the growing interest in the registry. As the hospitals for your support. The number 29 sites actively participating. Sites to of Hospital in NSW. Our coverage will be possible when Royal Brisbane in Newregistry growsa growth so has ourspurt! teamThisin theisphoto fantastic; than hospital / clinic sites continues to recently obtain approval to participateincrease Zealand has grown considerably and Women’s Hospital start recruitment. and below. all your efforts at contributing sites an with 34Dunedin, are: approved sites onand Wellington, board, and Whangarei greater We also hoperepresentation in Queensland to have Royal Darwin the growing interest in the registry. A 29 sites actively participating. Sites to will be possible when Royal Brisbane registry grows so has our team in the L-R: Elizabeth Moore, recently obtain approval to participate and Women’s Hospital start recruitment. below.Erica Wood, Laura Sellick, are: Dunedin, Wellington, and Whangarei We also hope to have Royal Darwin Cameron Wellard, Krystal Bergin, Neil Waters, L-R: Elizabeth Zoe McQuilten, Naomi Aoki, Moore Samantha Francis-Pester, Erica Wood, Laura S Andrew Spencer. Cameron Wellard, Krystal Bergin, Neil W Zoe McQuilten, Nao Samantha Francis-P MYELOMA 1000 PROJECT The Myeloma 1000 project involves will describe immunoglobulin use in Andrew Spencer. multiple collection of one blood sample from myeloma in Australia, including variation Recruitment to the Myeloma 1000 project, 1000 newly diagnosed patients with in practice, cost and patient outcomes. a blood biobank substudy of the registry, multiple myeloma before treatment has Results will inform policy and clinical has reached over 250 patients (see graph). commenced, and 1000 with MGUS. The practice related to immunoglobulin therapy Thanks to participating sites and patients project Theaims to establish a repository of in these patients. MYELOMA 1000 PROJECT for your collaboration. We have a couple of Myeloma 1000 project involves blood specimens that will be available will describe immunoglobulin use in m new sites with Princess Alexandra Hospital collection of one blood sample from myeloma in Australia, including variat Recruitment to the Myeloma 1000 project, for analysis and future assessment of in Brisbane and Canberra Hospital joining MRDR: HOW CANcost YOUand BEpatient outcome 1000 newly diagnosed circulating biomarkers that may better patients with in practice, a blood biobank substudy of the registry, recently; these are the first interstate sites, multiple myeloma before treatment hasINVOLVED? Results will inform policy and clinical hasandreached over that it is pleasing 250times patients (see graph). predict treatment response, and individuals to specimen commenced, at risk of developing and 1000orwith MGUS. The myeloma practice Ask your treating related specialist to immunoglobulin if your hospital th Thanks to participating reception sitesbeen in Melbourne have and within patients accelerated disease progression. project aims to establish a repository of in these contributes data to thepatients. MRDR and if you for the required your range. collaboration. We have a couple of blood specimens that will be available are eligible to participate. You will receive a new sites with Princess Alexandra Hospital IMPROVE for analysis and future assessment of patient information sheet about the registry STUDY in Brisbane and Canberra Hospital joining circulatingstudybiomarkers that may MRDR: HOW CAN YOU BE including how to opt off if you change your The IMPROVE (Immunoglobulins in bettermind. recently; these are the first interstate sites, predict myeloma treatment patients: researchresponse, and individuals into outcomes, INVOLVED? and it is pleasing that times to specimen variation in practice and epidemiology) at risk of developing myeloma or Ask your treating specialist if your ho reception in Melbourne have been within is a registry-based study funded accelerated disease by the progression. TO CONTACT THE MRDR: contributes data to the MRDR and if the required range. National Blood Authority through to 2020. Phone: 1800 811 326 Blood cancers, including multiple myeloma are eligible to participate. You will rec Email: sphpm-myeloma@monash.edu patient information sheet about the re IMPROVE STUDY are one of the most common indications Website: mrdr.net.au including how to opt off if you chang for immunoglobulin (Ig) use in Australia; The IMPROVE this practice studyand is quite costly (Immunoglobulins Ig use is in mind. Myeloma 1000 project participant accrual myeloma increasing with patients: a lot of research variation in into practice outcomes, variation and limited in practice oversight. and epidemiology) The IMPROVE study is a registry-based study funded by the TO CONTACT THE MRDR: National Blood Authority through to 2020. Phone: 1800 811 326 Blood cancers, including multiple myeloma Email: sphpm-myeloma@monas are one of the most common indications Website: mrdr.net.au for immunoglobulin (Ig) use in Australia; this practice is quite costly and Ig use is Myeloma 1000 project participant accrual increasing with a lot of variation in practice CRICOS Provider: Monash University 00008C. TRSU417824 and limited oversight. The IMPROVE study Support Line 1800 693 566 | MyeNews 9
President’s My Myeloma Report Journey Michelle, a Myeloma Australia member in South of those who do. Insights like this are so valuable, for Australia, wrote some prose in response to one empathetic support for each other and to those of us who try to provide support. of those feeling down days and posted it on a Facebook support page. She says “I really am Reading this will likely resonate with many people, the OK. Sometimes I get a bit down in the mouth response on Facebook has been impressive. Therefore, we wanted to share her words more widely with the hope (and write something like this), but then I pick to normalise these feelings but also as an opportunity to up pretty quickly afterwards. Photo supplied and used with permission remind everyone that there is help out there should these down days become more frequent. I sometimes feel guilty about having ‘down’ times, because compared to a lot of others, I’ve got it pretty cruisy at the We wish to highlight the fact that it’s ok to have days like moment. I guess it’s the unknown that gets to me, and I have these, but not every day. If you think a friendly chat would to keep telling myself to live in the present and not worry help getting out of these down days, why not call the about what’s coming up, because, really, no one ever knows Support Line for a listening ear from one of our nurses? that do they (smiley face)”. 1800 693 566 Monday – Friday, 9am – 5pm AEST. As a Myeloma Support Nurse, we aim to give support to We wish to thank Michelle for permission to share her those affected by myeloma through our expert knowledge thoughts with all our members. and learned experiences from people and their many Jo Gardiner different stories of myeloma. However, we can never really know what it is like to live each day with this disease. This Senior Specialist Myeloma Nurse poem beautifully opens a door to the everyday experience SA/NT Telephone Support Line Feedback Project At Myeloma Australia, we are continuously trying to improve how we support and assist people living with myeloma. One of our key services is our 1800 toll free Telephone Support Line. Myeloma Australia is currently evaluating the service we provide with our Telephone Support Line and we will be inviting callers to participate by providing feedback on your recent call by completing a short survey. Your participation is voluntary, and all responses are anonymous. We encourage you to participate to help Myeloma Australia continue to improve this service and ensure its effectiveness in meeting the needs of the myeloma community. If you wish further information about this, please call Jo Gardiner, Senior Myeloma Nurse Specialist and Project Leader on M: 0447 331 165 or email at jo.gardiner@myeloma.org.au Myeloma Support Line Monday – Friday 9am – 5pm (AEST) 1800 MYELOMA (1800 693 566) A confidential service providing those living with myeloma, their family and friends and health professionals access to specialist myeloma nurses. Open to anyone with a question about myeloma or just to have a chat. 10 MyeNews | www.myeloma.org.au
Who is that person in the mirror. You Look So Well That drawn face. Those black eyes. That curly flippin’ hair. “You look so well”. Haunted eyes look back at me. Hi. Haven’t seen you for so long. Where did all those lines come from? Heard you’ve been sick. Makeup is now my best friend. Cancer someone said. Is that true? But gee. You look so well. It’s been over a year. You must be better now. You look so well. Been sitting for a while now. Time to get up. Keep active. Keep fit. Stay healthy. Feet feel like I’ve walked for days, but its only 10am. Take the dog for a walk. Hips seized; Knees wont bend; Back hunched over. Why is this hill so hard. It never used to be. I shuffle like an old lady until I loosen up again. Pulse 180. Don’t think that’s good. But its ok. Because you look so well. Stars twinkling in front of my eyes. Still smile at the person walking past. Sore throat again. You look so well. That’s the 4th this winter. And we’re only half way through. So tired of feeling like crap. Parents getting pretty old now. But I don’t want summer to get here. They need more and more help. Because heat and I are no longer friends. I need to go to the doctors; the bank; You look so well. I’ve run out of milk they say. So tired, I’ll just rest my eyes at this traffic light. So how much longer will I have. What? Why are you tooting? Am I one that will last 20 years? Or will I be gone in 5? Oh the lights going yellow again now. Do we spend all our money making memories now? Geeze. You look so well. Or will that leave us with nothing if I survive a while? Certainly can’t fall back on that insurance we thought we had. So tired, fall to sleep as soon as head hits the pillow. But, oh, you look so well. But then there’s that dreaded hour. Without fail, you’re wide awake. What will the next treatment take from me. And then the mind games begin. My mind? If you’re lucky you’ll get back to sleep before My ability to drive? the alarm goes for another day. My ability to walk? Oh. You’re looking so well. My ability to wipe my own backside? But that will all be ok. Because, Its 2am and there’s a little whisper. You look so well. Mum. I can’t sleep. Can I have a cuddle? That’s every night for 2 weeks this time. I’m tired all the time. Every bone aches. How much do they have to suffer? But ask me and I’ll say I’m fine How can I ease their pain and reassure them? Work to be done; family to look after; house to run. I can’t because I won’t lie to them. Things don’t stop just ‘cause you’re sick. I don’t know what’s going to happen either. No one else to pick up the work You look so well. You look so well. Hot flushes, night sweats, kilos piling on. Hi. Haven’t seen you for so long. Oh. Hello menopause. You decided to join the party too. Heard you’ve been sick. Memory fails; Mind unable to focus on tasks; Cancer someone said. Is that true? confidence waning. It’s been over a year. You must be better now. Hey chemo. Anything else you want to take? You look so well. Wow. You didn’t lose weight during your Well. I’m not. treatment did you?! You look so well. Photo supplied and used with permission Support Line 1800 693 566 | MyeNews 11
Fundraising Congratulations and well done to all those who participated in Sydney’s City to Surf on Sunday 12th August. It was the launch of ‘Team Myeloma’ in NSW with 25 runners. On top of the successful running events in Perth and Melbourne, the city2surf is now firmly on our fundraising calendar. I ran 14km and felt ok by the end. I finished well but was feeling I could still run further… It has been suggested that a marathon may Team Myeloma be next on the cards for Jacqui and I who felt awesome at the end of the run. There are many more events coming up in Wants YOU in Sydney!! NSW, feel free to contact me or one of the Myeloma Australia team for more information. Santosh Ojha NSW Fundraiser Team Myeloma makes its Sydney debut at the City2Surf event on Sunday 12th August. Will you gather some friends and run with us? A social gathering of the myeloma community will be held following the event. Details can be found here: http://city2surf.com.au/ Any questions? Contact: matt.maudlin@myeloma.org.au Santosh pictured centre with Team Myeloma Santosh with Jacqui Keogh (bottom left) and Team Myeloma Photos supplied and used with permission Santosh (far right) with Team Myeloma Jacqui Keogh with Team Myeloma 12 MyeNews | www.myeloma.org.au
What’s President’s Happening Report Fundraising Australia practicalities render this impossible. Please do understand that your awareness and community fundraising The news from the community engagement and fundraising efforts are enormously appreciated and help us to continue realm of Myeloma Australia is short and sweet for this edition to expand our nurse led services providing education, only! But this is not to say that there is a lack of activity on support and advocacy to the myeloma community alongside these fronts – quite the opposite in fact! our commitment to myeloma research through our Medical and Scientific Advisory Group (MSAG). Santosh Ojha is settling nicely into his role as our NSW Fundraiser; having Sydney’s City2Surf event proved to be the The one awareness and fundraising idea I would like to ideal opportunity for Santosh to really get into the swing of leave you with is this …. Bunnings BBQ. A few supporters all things Myeloma Australia. in Perth made mention of such an event, and I wondered if other people would like to explore with their networks Team Myeloma debuted in Melbourne at Run Melbourne in the possibility of hosting a Bunnings BBQ (or similar) for late July with over 70 participants representing the Team. Myeloma Australia. If this is something that interests you Please keep an eye out for when Team Myeloma will be I would be happy to hear from you! participating at an event in a city near you!! And as I sign off, please remember that I am here to help! There is one upcoming fundraising event that I would I love hearing of your awareness raising and fundraising ideas particularly like to draw your attention to – this being – however great or small, madcap or sane, please let me hear the Athens Marathon that will be undertaken by Pana about them and help you to bring them to fruition! Karageorgiou in honour of his late father, Manny. Pana’s story can be found here: Kind regards, https://give.everydayhero.com/au/spartan-run Matt Maudlin, Community Engagement & Fundraising Manager As much as I would like to feature each and every fundraising M: 0407 891 052 activity that occurs in the community on behalf of Myeloma E: matt.maudlin@myeloma.org.au Did you know that you can donate to us through your pay? Workplace giving streamlines our financial management of It’s easy and quick, tax benefits are immediate and there’s no corporate donations and reduces our administration. Ninety need to organise receipts at the end of June. It even has the nine per cent of all donations reach charities on the Platform, possibility to double your donation to us! and 70 per cent of the companies match their employee donations! We’re listed on the Good2Give workplace giving Platform. Scroll to the bottom of www.good2give.ngo and see if your You can even fundraise for us if your employer is listed on employer is one of the 150 companies in the scroll bar. If Good2Give, and channel your donations through workplace your company isn’t yet on Good2Give, direct your corporate giving, again, potentially doubling your result! responsibility or payroll teams to www.good2give.ngo and suggest they request a demo. Any questions? Please contact Matt at Myeloma Australia: matt.maudlin@myeloma.org.au Support Line 1800 693 566 | MyeNews 13
From President’s the Nurse Report Manager I’m pleased to once again have many exciting things to Jo and Jacqui have been working on a survey to evaluate report in this edition from the Nurse Manager chair. Nella and our toll-free 1800 MYELOMA (693 566) Support Line. We I are so proud of the work our Myeloma Support Nurses are would really appreciate your honest feedback so that we can doing on the ground in their states and know many of you continue to improve this invaluable service. If you utilise the are seeing the benefits of a nurse in your area. The expansion Support Line you will be asked if you’re happy to receive the project is far from complete so if we currently don’t have a survey. Participation is completely voluntary and certainly nurse in your state, there may well be very soon. not a requirement to use the Support Line. We have now appointed two nurses in Queensland, As a group, the nurses have been working hard to bring to Tash Clarke and Megan McDowell. They both bring with you both updated and new information. them a wealth of experience working with people with We now have fact sheets about thalidomide, lenalidomide, myeloma across many different settings and will commence pomalidomide, bortezomib, carfilzomib, ixazomib, employment soon. They are very keen to start engaging the daratumumab, venetoclax and steroids available for community and provide our services to those in QLD. We will download on the website with associated quick reference introduce them in the next edition of MyeNews. We are very cards printed. much looking forward to welcoming them to the team. We also have resources to help you know how to ‘live well’ In Western Australia, Kerin and Narelle have moved into a with myeloma. Speak with our Myeloma Support Nurses on new office space within the Solaris Cancer Centre in Cottesloe 1800 693 566 if you would like to discuss which resources are and are really enjoying the extra space and access to other suitable for you. like-minded organisations and wellness services within the building. Stay tuned for their grand plans for WA in 2019. If you would like any of our resources from the website but don’t have a printer you are most welcome to request a print In NSW Geo Sobrio has joined Jacqui and Santosh in their out from head office via support@myeloma.org.au . new office space and has already hit the ground running… literally, with all three staff members participating in the Did you know that the flu season can continue past winter City2Surf fun run in August. You can read more about Geo in into spring? There is still time to get the flu vaccine if you his profile in this edition of MyeNews. I’m sure you’ll all join haven’t done so already. Not only is it important for people me in extending a warm welcome to Geo. with myeloma to have the flu vaccine due to having a compromised immune system but it is also important for Elli and Laura are now well and truly part of the furniture family and friends to also be protected against the flu to in Victoria and are managing to spread themselves far reduce the risk of passing the virus on. and wide. They too have grand plans to reach even further in 2019. We hope that you have managed to get through the winter unscathed and are now able to see a glimpse of spring on South Australia have also managed to increase their services the way. without any extra staff members with the help of some motivated local health professionals and our ever-faithful SA Hayley Beer volunteer committee led by Jo Gardiner. Myeloma Support Nurse Manager TREATMENT FACT SHEET TREATMENT FACT SHEET SHEET NT FACT TREATME Ixazomib (Ninlaro® ) Carfilzomib (Kyprolis ) ® e® ) ib (Velcad Bortezom for use in What is ixazomib? When is carfilzomib available al Benefits Like bortezomib (Velcade®) How is ixazomib given? is carfilzomib? Australia on the Pharmaceutic and carfilzomib (Kyprolis®), What known as proteasome belongs to a group of drugs known as proteasome ixazomib Ixazomib can be given for belongs to a group of drugs Scheme (PBS)? inhibitors. on its own or in combination ib available Carfilzomib Ixazomib is the first l as bortezomib (Velcade®) oral (by mouth) proteasome myeloma treatments. with other which is the same family of drugs maceutica with a the PBS in combination It is usually taken on bortezom inhibitors developed, this means inhibitor to be has been developed to target Carfilzomib is subsidised through a 28 day cycle. days 1, 8 and 15 of When is ralia on the Phar has it can be taken at home and ixazomib (Ninlaro®). Carfilzomib bortezomib. This is thought to for patients whose myeloma being administered as a tablet instead of to steroid medication, dexamethasone of treatment. in the hospital. Ixazomib is usually continued a different part of the proteasome potentially cause fewer side use in Aust (PBS)? Scheme the PBS for people ed who are newlysis, itcarfilzomib make can more effective and returned after already having one type as part of a clinical trial in signs of increasing. until the myeloma is showing ib? known as Benefits It is also possible to have carfilzomib doctor can advise when a How does ixazomib bortezom s to a group of drugs What is (Velcad as carfilzo mib is subsidi at diagno sed on than bortezomib. effectss on nt was prescribsubsidised depend if combination with other therapies. The work? e®) belong same family Bortezomib if another treatme r of cycles and Proteasomes are large When is ixazomib available or transplant clinical trial is appropriate. molecules which are t of time. does carfilzomib work? the Bortezomib inhibitors. It is in diagnosed a later date. The numbe ous stem cell body. They are involved present in the removal, breakdown in all cells in the proteasome ib (Ninlaro ®). be given at a plan for an autolog a certain amoun How , the are present in all cells in the of damaged proteins or those that are no and recycling Australia on the Pharmace for use in (Kyprolis®) and ixazom there is whether mib is proving effectiv e after disease stage of the Proteasomes are large molecules which removal, breakdown and recycling How to tell if carfilzomibsymptoms is working? cell. Proteasome inhibitors longer needed by the Scheme (PBS)? utical Benefits ib work? during one work by binding to proteasomes the the bortezo effective at relapse. body. They are involved in the the caused by the temporarily blocking all cells in that are no longer needed by in the and bortezom their present in recycling mib has been of damaged proteins or those Patients may observe a reduction doctor down unwanted proteins. function, which stops them from breaking The Australian Therapeutic nt again by binding to proteasomes and improved quality of life. The How does which are If bortezo Goods Administration molecules own and se treatme cell. Proteasome inhibitors work myeloma associated with an become toxic, killing This causes proteins approved ixazomib (TGA) have are large l, breakd by the PBS will subsidi ing stops them from breaking of each treatment cycle to monitor the cell. to build up and as a safe and effective blocking their function, which will also order tests at the start ib is work has not yet been listed treatment. However, Proteasomes d in the remova longer needed and temporarily causes proteins to build up and from patient to patient but generally Myeloma cells multiply more to be subsidised by is that are no to proteasomes if bortezom response. These tests may vary are involve by the Benefits Scheme (PBS). the Pharmaceutical body. They proteins or those g down unwanted proteins. This caused urine testing and occasional x-rays or quickly than normal symptoms The doctor toxic, killing the cell. How to tell from breakin rely more heavily on healthy cells and ed by binding on in the include regular blood and/or proteasomes as they of damag ome inhibitors work n, which stops them up and a reducti quality of life. become r at a faster rate. Myeloma produce unwanted proteins It may be available via s to build may observewith an improved cycle to monito than normal healthy cells and bone marrow biopsies. cells are therefore much clinical clinical trial is an appropriate trials in some states. Ask the doctor cell. Proteas blocking their functio Patients treatment Myeloma ly multiply more quickly cells ixazomib than normal more sensitive to if a causes protein associated the start of each but general produce unwanted proteins cells. option when new treatment temporarily ed proteins. This and myeloma to patient relyx-rays moreor heavily on proteasomes as they sensitive to is required. at cells are therefore much more effects? Myeloma cells appear healthy cells order tests may vary from patient What are the potential side nal down unwant killing the cell. s and occasio at a faster rate. Myeloma to be even more dependent become toxic, than normal e unwanted protein will also These tests and/or urine testing carfilzomib than normal cells. They proteasomes than other types of cancer cells. on the actions of How to tell if ixazomib cells multipl y more quickly as they produc more sensitiv e to response. blood even more dependent on the actions of As with all drugs, carfilzomib has many potential side effects. or the need of the myeloma This may be due to Patients may observe is working? Myeloma proteasomes re much include regularbiopsies. Myeloma cells appear to be to patient and may be mild cells (paraprotein) they produce. to dispose of the abnormal protein a reduction in the symptoms heavily on a cells are therefo of cancer cells. This may be due to can vary considerably from patient to lower the myeloma associated rely more of bone marrow proteasomes than other types way to reduce side effects is with an improved quality caused by the rate. Myelom on the actions cells to dispose of the abnormal protein more serious. Often the best on efficacy. As By blocking the function of the proteasome, will also order tests of life. The doctor at a faster than normal cells. ent to the need of the myeloma do this without compromising at the start more dependThis may be due dose. It is possible to tomyeloma cells from growing ixazomib prevents the response. These tests of each treatment cycle bortezomib to be even (paraprotein) they produce. or managed, it is very important and multiplying. may vary from patient to monitor cells. cells appear types of cancer of the abnormal protein the side effects can usually be treated include regular blood to patient but generally Myeloma proteasome, carfilzomib prevents them promptly to the doctor or nurse. and/or urine testing than other to dispose By blocking the function of the highlight bone marrow biopsies. and occasional x-rays proteasomesthe myeloma cells ts myeloma cells from growing and multiplying. or the need of e. mib preven (paraprotein) they produc ome, bortezo Heart problems n of the proteas to cause heart problems or worsen pre How is carfilzomib given? intravenous (IV), into the ying. g the functio g and multipl Carfilzomib has been found By blockin a cells from growin patients being treated with to 30 minute existing heart conditions. Therefore, during treatment. Symptoms the myelom Carfilzomib is given as an up height and carefully be calculated on the patient’s carfilzomib will be monitored given? aneous), vein infusion. The dose will blood pressure, shortness of breath, ezomib n under the skin (subcut if dose for the first cycle. Then of heart problems include high weight and will begin as a smaller How is bort increased. lower limbs and/or hands. an injectio an injection into the vein of concerns, the dose will be chest pain and swelling in the in there are no major side effects about any history of heart problems is given as as e when used will be given prior to the It is important to tell the doctor Bortezomib be given be most effectivas chemotherapy For the first cycle only, IV hydration to report any of the above side effects cases it can shown to before starting carfilzomib and or in some It has been nts such carfilzomib infusion. a treatme and 16 of a 28 day cycle. immediately once treatment starts. (intravenous).with other myelom 35 day Carfilzomib will be given on days 1, 2, 8, 9, 15 or to combinations. 22 or a 28 of a 28 combination with other medications it 8, 15 and 8 and 11 Carfilzomib is often given in and steroid on days 1, days 1, 4, until the myeloma shows signs is often given given on increase the efficacy. It is continued if the side effects of treatment Bortezomib cases it may be is beginning to become active again or some cycle. In become intolerable. day cycle. The information in this fact sheet is not the treating team. intended to replace advice of replace medical care or the advice of A doctor should always medical care or the advice of care or the ment. fact sheet is not intended to be consulted regarding ce medical and treat The information in this regarding diagnosis and treatment. diagnosis and treatment. ded to repla ding diagnosis the treating team. A doctor should always be consulted is not inten lted regar fact sheet be consu ation in this d always The inform team. A doctor shoul ing the treat FACT SHE ET TREATMENT FACT SHEET TREATMENT FACT SHEET Find our Treatment Fact Sheets TREATMENT ide (Revli mid ) ® Pomalidomide (Pomalyst ) ® Thalidomide (Thalomid®) under the resources tab of our website Lenalidom for When is pomalidomide available www.myeloma.org.au What is Pomalidomide? use in Australia on the Pharmaceutical belongs to a group of Pomalidomide, also known as Pomalyst®, drugs called immunomodulatory drugs (IMiD) which work by Benefits Scheme (PBS)? What is thalidomide? in is a collection on the PBS for patients where Thalidomide can also be used able for usemodifying the immune system. The immune system In Australia pomalidomide is subsidised Thalidomide, also known as as maintenance therapy after the body from infection at least two prior therapies Thalomid®, belongs to a group autologous stem cell transplant. idomide avail fits tissues and organs that help to protect their myeloma has progressed through called immunomodulatory drugs of drugs This is a continuous daily dose Beneof aceutical as well as lenalidomide. When is lenal (IMiD) which work by modifying help consolidate the effects to and against disease. and have progressed on bortezomib the immune system. The immune of the transplant. on the Pharm similar chemical system is a collection of tissues is a third generation IMiD and has a and organs that help to protect Australia ? Pomalidomide nt such as thalidomide if pomalidomide is working the body from infection and against lidomide? ®, belongs to a groupbyof to other immunomodulatory drugs, transpla disease. First prescribed in the Scheme (PBS) us stem cell structure How to tell 1950s for nausea and insomnia When is thalidomide available What is Lena is for an autologowell, lenalidomide and lenalidomide which are also used to treat myeloma. pregnant women, thalidomide in as Revlimid also known which work (IMiD) n For people who are eligible fit and age of 70 and time of first, or subsequ ent, Patients may observe a reduction in the symptoms caused by the quality of life. The doctor when it was found to cause was taken off the market in the 1960s Australia on the Pharmaceutic for use in Lenalidomide, immunomodulat ory drugs is a collectio immune systemfrom infection (ASCT), ie. Under the PBS at the myeloma associated with an improved can be used to treat diseases birth defects. Scientists then discovered it Scheme (PBS)? al Benefits How does Pomalidomide work? treatment cycle to monitor of the immune system such drugs called immune system. The body through the will also order tests at the start of each as myeloma. the protect the subsidised lenalidomide patient to patient but generally Thalidomide has a similar chemical structure to modifying that help to le for ASCT, than conventional response. These tests may vary from other next generation In Australia thalidomide is subsidised and organs l relapse. ed unsuitab in their disease which Pomalidomide is a more targeted therapy testing and occasional x-rays or immunomodulatory drugs, on the PBS at different stages of tissues a similar chemica who are consider time and is thought to have several mechanisms of action include regular blood and/or urine such as lenalidomide and pomalidomide during the course of the disease. It may be prescribed at diagnosis, disease. IMiD and has ide For people through the PBS at any or if these patients eligible werechemotherapy of action which are also used to treat myeloma. at relapse or for maintenance and against generation drugs, such as thalidom ed is for be that affect myeloma cell survival. However, the mechanism bone marrow biopsies. therapy after an autologous is a second modulatory is subsidis time of initial diagnos diagnosis, they will cell transplant. If thalidomide stem Lenalidomide myeloma. at cannot be tolerated, there are other immunoare also used to treat can be at the medication is not fully understood. How does thalidomide work? treatment options available. other structure to omide which prescrib ed a different date. later Pomalidomide is thought to work in the following ways: What are the potential side effects? and pomalid at a Thalidomide is a more targeted ? lenalidomide ing? 1. Directly killing or stopping the growth of myeloma cells As with all drugs, pomalidomide has many potential side effects. therapy than conventional lenal idomide work ional lenal idom ide is work 2.by the the immune response against the myeloma cells They can vary considerably from patient to patient and may be mild chemotherapy and is thought to have several mechanisms of action How to tell if thalidomide is working? How doesis a more targeted therapy convent if Boosting is to lower that affect How to tell a reduction in the than action s caused to reduce side effects myeloma cell mechanisms of symptom messages involved in the or more serious. Often the best way survival. However, the mechanism Patients may observe a reduction have several mechanism of action life. The doctor 3. Altering the production of chemical compromising on efficacy. Asis not fully understood. of action in the symptoms caused by Lenalidomide and is thought to observe d quality of the dose. It is possible to do this without myeloma associated with an the However, the Patients may with an improve treatment cycle growth and survival of myeloma cells to monitor managed, it is very important to Thalidomide is thought to work improved quality of life. The doctor chemotherapy cell survival. associated generally supply the side effects can usually be treated or in the following ways: will also order tests at the start of each treatment cycle to monitor myeloma myeloma start of each patient but4. Blocking the growth of new blood vessels that or nurse. that affect tests at the patient to x-rays or highlight them promptly to the doctor 1. Directly killing or stopping response. These tests may vary from patient to patient but generally understood. the followin g ways: will also order tests may vary from occasional myeloma cells with oxygen and nutrition (anti-angiogenesis) the growth of myeloma cells include regular blood and/or is not fully to work in These testing and 2. Boosting the immune response urine testing and occasional is thought myeloma cells response. and/or urine myeloma cells from sticking to the bone marrow. against the myeloma cells bone marrow biopsies. x-rays or Lenalido mide the growth of a cells blood include regularbiopsies. 5. Preventing the Birth defects 3. Altering the production killing or stopping the myelom pomalidomide are educated on growth of chemical messages involved 1. Directly response against in the bone marrow Both men and women who are taking and survival of myeloma cells in the ts? asked strictly not to reproduce 2. Boosting the immune ion of chemica l message s involved tial side effec HowThey is pomalidomide given? the risks to an unborn child and are has a pregnancy 4. Blocking the growth of new What are the potential side effects? the poten potential sidebe effects. The tablets while taking pomalidomide. The manufacturer pomalidomide is blood vessels that supply the What are lenalidomide has many comes in tablet form and is taken orally. the product myeloma cells mild or myeloma cells with oxygen and As with all drugs, thalidomide 3. Altering survival of supply the and may Pomalidomide be taken either with prevention programme in place to ensure that nutrition (anti-angiogenesis) has many potential side effects. growth and vessels that giogenesis) to patient to lower swallowed whole with water and can be the taken safely. 5. Preventing the myeloma can vary considerably from patient They of new blood (anti-an with all drugs, patient effects should is any time of the day stored, prescribed, handled and cells from sticking to patient and may be the growth nutrition As ably from side Asfood. Pomalidomide can be taken at to the bone marrow more serious. Often the best mild or 4. Blocking cells with oxygen and the bone marrow. can vary consider way to reduce or without ising on efficacy. nt to the same time each day. way to reduce side effects is Often the best without comprom to lower the myeloma sticking to but it is best to take it at approximately dose. It is possible to do this without ng the myelom a cells from more serious. do this possible to be treated or manage d, it is very importa days followed by a seven-day rest How is thalidomide given? side effects can usually be treated compromising on efficacy. As 5. Preventi dose. It is Pomalidomide usually taken for 21 or managed, it is very important can usually to the doctor or nurse. Most people will continue this Thalidomide comes in tablet highlight them promptly to to ? side effects which completes the 28-day cycle. form and is taken orally; the the doctor or nurse. idomide given promptly response has been achieved or should be swallowed whole tablets The tablets highlight them regime until it is thought that a deep at least an hour after food. Thalidomide How is lenal form and is comes in tabletwith water and can taken orally. either with be taken day but s the myeloma are educate d onis showing signs of increasing. can be taken at any time of the feel drowsy. It is for this reason day however it can cause patients to Birth defects time of the lenalidomide Pomalidomide ce is often given in combination with a steroid tablet, Birth defect Both men and women who are Lenalidomide whole taken at any who are taking not to reprodu taken in the evening just before that it is often recommended that it be taking thalidomide are educated swallowed mide can be same time each day. asked strictly a pregnan bed. the risks to an unborn child on should be Both men and women child and are cy dexamethasone. and are asked strictly not to food. Lenalido ately the rest turer has Thalidomide is usually taken while taking thalidomide. The reproduce or without a seven-day the risks to an unborn The manufac lenalidomide is stored, for 21 days followed by a seven manufacturer has a pregnancy take it at approxim 21 days followed by this lenalidomide.place to ensure that which completes the 28 day day rest prevention programme in place it is best to taken for will continue or while taking in cycle. It is commonly given in combination prescribed, handled to ensure that thalidomide is usually Most people achieved program me with a chemotherapy tablet and stored, Lenalidomide es the 28-day cycle. response has been and steroid tablet that are prescribed taken safely. prevention taken safely. once per week during the 21 handled and day period of the cycle. Most which completis thought that a deep prescribed, people will it increasing. tablet, and continue this regime until it is thought that a deep response regime until is showing signs of a steroid achieved or the myeloma is showing signs has been a tion with the myelom in combina of increasing. is often given agents. Lenalidomide with chemotherapy also sometimes care or the advice of is not intended to replace medical The information in this fact sheet and treatment. always be consulted regarding diagnosis the treating team. A doctor should The information in this fact sheet is not intended to replace advice of the treating team. A doctor medical care or the advice care or the should always be consulted of e medical treatment. regarding diagnosis and treatment. ed to replac ing diagnosis and is not intend regard fact sheet consulted ation in this r should always be The inform docto treati ng team. A the 14 MyeNews | www.myeloma.org.au
You can also read